Physician profile
Harsh Patel
NPI 1467980045
$933.76
in general payments reported to CMS, 2019-2025
14 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $52.01 · 2021: $325 · 2022: $53.25 · 2023: $132 · 2024: $44.06 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $158.85 | 2023-2024 | Lux-Dx Insertable Cardiac Monitor |
| Stryker Corporation | $148.86 | 2025 | Sonopet Iq, Na |
| Argenx US, INC. | $110.57 | 2025 | Vyvgart |
| Olympus America INC. | $105.49 | 2021 | |
| Genzyme Corporation | $91.86 | 2021-2023 | |
| Amgen INC. | $57.42 | 2021 | |
| Ucb, INC. | $55.69 | 2022-2025 | Nayzilam |
| Genentech USA, INC. | $52.01 | 2020 | |
| Sanofi-Aventis U.S. LLC | $42.02 | 2021 | |
| Shockwave Medical, INC | $31.88 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $29.04 | 2021 | |
| Abbvie INC. | $19.10 | 2022 | |
| Alnylam Pharmaceuticals INC. | $16.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harsh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.